ArticleJournal of clinical hypertension (Greenwich, Conn.)2016

Mineralocorticoid Receptor Antagonism for Cardiovascular Protection in End-Stage Renal Disease: New Data But the Controversy Continues.

Panagiotis I Georgianos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.